Biomet SpinalPak Non-invasive Spine Fusion Stimulator System- Indicated for the treatment of an ...
FDA Device Recall #Z-1616-2024 — Class II — March 22, 2024
Recall Summary
| Recall Number | Z-1616-2024 |
| Classification | Class II — Moderate risk |
| Date Initiated | March 22, 2024 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | EBI, LLC |
| Location | Parsippany, NJ |
| Product Type | Devices |
| Quantity | N/A |
Product Description
Biomet SpinalPak Non-invasive Spine Fusion Stimulator System- Indicated for the treatment of an established nonunion acquired secondary to trauma, excluding vertebrae and all flat bones, Part Number: 1067716
Reason for Recall
Damage to the lead wire sheath (black cable) component and causing exposure of the wires, potentially lead to no therapeutic treatment signal being delivered to the electrodes, and result in delay of treatment
Distribution Pattern
US Nationwide distribution.
Lot / Code Information
UDI-DI: 00812301020218 All devices distributed since May 1, 2023
Other Recalls from EBI, LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1617-2024 | Class II | Biomet OrthoPak Non-invasive Bone Growth Stimul... | Mar 22, 2024 |
| Z-1619-2024 | Class II | 48" Lead Wires, Replacement Part Number: 10677... | Mar 22, 2024 |
| Z-1618-2024 | Class II | 20" Lead Wires, Replacement Part Number: 10677... | Mar 22, 2024 |
| Z-0874-2015 | Class II | Solitaire-C Cervical Spacer System a) 14-531... | Nov 11, 2014 |
| Z-0909-2015 | Class II | Cypher MIS Screw System-The system includes scr... | Oct 8, 2014 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.